Copy Link Print Information

Izalontamab

(Synonyms: SI-B001; BL-B01D1 Antibody)
고객리뷰

Based on 1 Customer Validation

Izalontamab (SI-B001) is a bispecific anti-EGFR/HER3 monoclonal antibody with high selectivity for EGFR/HER3 heterodimer. Izalontamab can be used for the research of cancer.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Izalontamab
  • Experimental Validation Results for Izalontamab
  • Experimental Validation Results for Izalontamab
  • Experimental Validation Results for Izalontamab
  • Experimental Validation Results for Izalontamab
  • Izalontamab Chemical Structure
    Izalontamab Chemical Structure
CAS No.: 2559704-24-2
사이즈
가격
재고
수량
Amount: USD 0.00
Please select quantity
or
or

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Izalontamab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
주변의 대리점 찾기 Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

All EGFR Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress 로그인
Register
Sign in to MedChemExpress
회원가입

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa-[scFv-heavy-lambda]2

  • 1/16

    Immobilized Human HER3/ERBB3 Protein (ECD, His Tag) can bind Izalontamab. The EC50 for this effect is 1.98 ng/mL.

  • 1/16

    Immobilized Human EGFR Protein (ECD, His Tag) can bind Izalontamab. The EC50 for this effect is 2.53 ng/mL.

  • 1/16

    Flow Cytometry analysis of Hela cells labelling EGFR (red) with Izalontamab (HY-P99676). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • 1/16

    Flow Cytometry analysis of MCF-7 cells labelling ERBB3 (red) with Izalontamab (HY-P99676). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Izalontamab Chemical Structure
    1/16
  • Izalontamab
  • Immobilized Human HER3/ERBB3 Protein (ECD, His Tag) can bind Izalontamab. The EC50 for this effect is 1.98 ng/mL.
  • Immobilized Human EGFR Protein (ECD, His Tag) can bind Izalontamab. The EC50 for this effect is 2.53 ng/mL.
  • Flow Cytometry analysis of Hela cells labelling EGFR (red) with Izalontamab (HY-P99676). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Flow Cytometry analysis of MCF-7 cells labelling ERBB3 (red) with Izalontamab (HY-P99676). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • IgG1-kappa-[scFv-heavy-lambda]2